
Product Usage: This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals. It is not approved for human or animal consumption. Misuse, misbranding, or mislabeling as a drug, food, or cosmetic is strictly prohibited. All information provided is for educational purposes only.
Cagrilintide
£149.99
In stock
Research suggests this investigational peptide may interact with the calcitonin receptor with potentially enhanced pharmacokinetic properties. Studies indicate it may influence cellular signaling through three primary mechanisms: receptor interaction, cellular processes, and what appears to be observed in gastric activity. Preliminary clinical data suggests there may be notable laboratory measurements, particularly in type 2 diabetes contexts. The compound's modified structure may exhibit different stability profiles compared to native amylin, potentially allowing for sustained receptor interaction. Current investigations are assessing its possible applications in obesity and metabolic research. The compound requires proper reconstitution prior to administration according to laboratory protocols.
Loading stock...
Size:
12 mg
Ships tomorrow morning if ordered by 2PM UTC
Free international delivery within 1-3 business days on orders over £250, with a tracking number provided.
Third party tested
FREE Bacteriostatic Water
For every £75 you spend, get 1 FREE bottle of Bacteriostatic Water to reconstitute your peptides.


Cagrilintide
£149.99
In stock
Buy 3+ for £50 each and save 5%
Buy 5+ for £50 each and save 8%
Buy 10+ for £50 each and save 10%
Loading stock...
Size:
12 mg
Ships tomorrow morning if ordered by 2PM UTC
Free international delivery within 1-3 business days on orders over £250, with a tracking number provided.
Third party tested
FREE Bacteriostatic Water
For every £75 you spend, get 1 FREE bottle of Bacteriostatic Water to reconstitute your peptides.
Research suggests this investigational peptide may interact with the calcitonin receptor with potentially enhanced pharmacokinetic properties. Studies indicate it may influence cellular signaling through three primary mechanisms: receptor interaction, cellular processes, and what appears to be observed in gastric activity. Preliminary clinical data suggests there may be notable laboratory measurements, particularly in type 2 diabetes contexts. The compound's modified structure may exhibit different stability profiles compared to native amylin, potentially allowing for sustained receptor interaction. Current investigations are assessing its possible applications in obesity and metabolic research. The compound requires proper reconstitution prior to administration according to laboratory protocols.
Product Usage: This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals. It is not approved for human or animal consumption. Misuse, misbranding, or mislabeling as a drug, food, or cosmetic is strictly prohibited. All information provided is for educational purposes only.
Characteristics
Molecular Formula
C225H348N60O68
CAS Number
2023788-19-2
Molar Mass
5047.61g/mol
Amino Acid
Sequence
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
Synonyms
LY3298176
Solubility
Water-soluble |
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder - requires reconstitution
How does Cagrilintide work?
Cagrilintide's mechanism of action may primarily involve its role as a long-acting amylin analog that may interact with the calcitonin receptor. The peptide may demonstrate enhanced receptor activity compared to native amylin, with potentially improved pharmacokinetic properties.
Research
Physiological Processes: Research suggests it may influence physiological processes through possibly enhanced signaling and potentially altered intake.
Metabolic Markers: Studies indicate it may influence laboratory markers and may offer potential for research in type 2 diabetes contexts.
Extended Duration: The modified structure may provide a longer half-life compared to native amylin, potentially allowing for less frequent laboratory administration.
Gastric Function: Research suggests it may influence gastric emptying rates, potentially contributing to observed laboratory measurements.
Combination Potential: Studies suggest there may be possible synergistic effects when examined with other metabolic agents.
Side Effects
Clinical research suggests Cagrilintide may be generally well-tolerated. Commonly reported effects in studies may include:
Gastrointestinal observations during initial administration
Administration site reactions
Mild and transient nausea
Summary
Cagrilintide may represent an advancement in amylin analog research, particularly in the field of metabolic research. Its modified structure may provide enhanced pharmacokinetic properties while potentially maintaining the receptor activity of amylin. Current research suggests there may be promising applications in areas related to metabolism, with ongoing studies exploring additional research potential.
Characteristics
Molecular Formula
C225H348N60O68
CAS Number
2023788-19-2
Molar Mass
5047.61g/mol
Amino Acid
Sequence
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
Synonyms
LY3298176
Solubility
Water-soluble |
Organoleptic Profile
White to off-white powder
Composition
Lyophilized powder - requires reconstitution
How does Cagrilintide work?
Cagrilintide's mechanism of action may primarily involve its role as a long-acting amylin analog that may interact with the calcitonin receptor. The peptide may demonstrate enhanced receptor activity compared to native amylin, with potentially improved pharmacokinetic properties.
Research
Physiological Processes: Research suggests it may influence physiological processes through possibly enhanced signaling and potentially altered intake.
Metabolic Markers: Studies indicate it may influence laboratory markers and may offer potential for research in type 2 diabetes contexts.
Extended Duration: The modified structure may provide a longer half-life compared to native amylin, potentially allowing for less frequent laboratory administration.
Gastric Function: Research suggests it may influence gastric emptying rates, potentially contributing to observed laboratory measurements.
Combination Potential: Studies suggest there may be possible synergistic effects when examined with other metabolic agents.
Side Effects
Clinical research suggests Cagrilintide may be generally well-tolerated. Commonly reported effects in studies may include:
Gastrointestinal observations during initial administration
Administration site reactions
Mild and transient nausea
Summary
Cagrilintide may represent an advancement in amylin analog research, particularly in the field of metabolic research. Its modified structure may provide enhanced pharmacokinetic properties while potentially maintaining the receptor activity of amylin. Current research suggests there may be promising applications in areas related to metabolism, with ongoing studies exploring additional research potential.
Subscribe to our newsletter
Receive weekly updates with the newest insights, trends, and tools, straight to your email.

PEPTIDE
SUPPLIED
Contact Us
Email:
support@peptidesupplied.com
Peptides
Company
All products on this site are intended for research and development purposes only and are not meant for human consumption of any kind. Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
© 2025, Peptide Supplied™. All Rights Reserved.
Subscribe to our newsletter
Receive weekly updates with the newest insights, trends, and tools, straight to your email.

PEPTIDE
SUPPLIED
Contact Us
Email:
support@peptidesupplied.com
Peptides
Anti-Aging
Anti-Inflammatory
Cardiovascular Health
Endocrinology
Energy Support
Immunomodulator
Longevity
Metabolic Regulation
Nootropic
Reproductive Health
Sleep/Circadian Rhythm
Tissue Repair & Regeneration
Weight Management
Company
All products on this site are intended for research and development purposes only and are not meant for human consumption of any kind. Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
© 2025, Peptide Supplied™. All Rights Reserved.